Mechanism of Rhizoma Coptidis in epilepsy with network pharmacology

Main Article Content

Dan Huang
Yan Lv
Chuansen Lu
Bo Zhang
Zongjun Fu
Yingliu Huang

Keywords

Rhizoma Coptidis, epilepsy, molecular docking, network pharmacology

Abstract

Network pharmacology is a bioinformatics-based research strategy aimed at identifying drug actions and facilitating drug discovery. In this study, network pharmacology was used for exploring the anti-epileptic multi-target mechanism of Rhizoma Coptidis. The possible protein targets of Rhizoma Coptidis were predicted by constructing the pathway and network of drug targets. Then, the interaction of the main active components of Rhizoma Coptidis and predicted candidate targets were verified using molecular docking technology. Finally, nine active compounds were selected from Rhizoma Coptidis. A total of 68 targets associated with Rhizoma Coptidis treating epilepsy. The key targets were AKT1, IL6, VEGFA, and TP53. According to GO functional enrichment analysis, 289 items of biological process, 33 items of cellular component, and 55 items of molecular function were obtained. A total of 89 signaling pathways were identified through KEGG pathway enrichment analysis (P < 0.05), and HIF-1, TNF, and T-cell receptor signaling pathways were mainly related to epilepsy. Molecular docking showed quercetin and (R)-canadine combined well with the key targets. The active ingredient in Rhizoma Coptidis can regulate various signaling pathways, and have therapeutic effects on epilepsy.

Abstract 85 | PDF Downloads 61 HTML Downloads 85 XML Downloads 1

References

1. Wennberg R, Hiploylee C, Tai P, et al. Is concussion a risk factor for epilepsy? Can J Neurol Sci. 2018;45:275–282. 10.1017/cjn.2017.300

2. Uslu FI, Gokcal E, Gelisin O. Epilepsy-related knowledge and attitudes toward people with epilepsy among hospital staff in Van City, Turkey. Epilepsy Behav. 2020;103. 10.1016/j.yebeh.2019.04.014

3. Casotto V, Ranzato F, Girardi P, et al. Increasing epilepsy-related mortality: A multiple causes of death study in Northern Italy. Seizure-Eur J Epilep. 2022;94:1–6. 10.1016/j.seizure.2021.11.003

4. Ru YD,Li JB, Chen HY, et al. Epilepsy Detection Based on Variational Mode Decomposition and Improved Sample Entropy. Comput Intel Neurosc. 2022. 10.1155/2022/6180441

5. Lu L, Jia Y, Kirunda JB, et al. Effects of noise and synaptic weight on propagation of subthreshold excitatory postsynaptic current signal in a feed-forward neural network. Nonlin Dynam. 2019;95:1673–1686. 10.1007/s11071-018-4652-9

6. Triplet EM, Nickels K , Wong-Kisiel L, et al. A tale of two cohorts: Differing outcomes in infantile-onset focal epilepsy. Epilepsia. 2022. 10.1111/epi.17181

7. Xia L, Liu L, Wang Q, Relationship Between the Pyroptosis Pathway and Epilepsy: A Bioinformatic Analysis. Front Neurol. 2022; 10.3389/fneur.2021.782739

8. Patel DC, Tewari BP, Chaunsali L, et al. Neuron-glia interactions in the pathophysiology of epilepsy. Nat Rev Neurosci. 2019;20:282–297. 10.1038/s41583-019-0126-4

9. Deng P, Liang H, Xie KM, et al. Study on the molecular mechanism of Guizhi Jia Shaoyao decoction for the treatment of knee osteoarthritis by utilizing network pharmacology and molecular docking technology. Allergol Immunopath. 2021;49(6):16–30. 10.15586/aei.v49i6.484

10. Dong YK, Tao B, Xue X; et al. Molecular mechanism of Epicedium treatment for depression based on network pharmacology and molecular dockingtechnology. BMC Complement Med. 2021;21(1):1–13. 10.1186/s12906-021-03389-w

11. Roh KB, Ryu D, Cho E, et al. Coptis chinensis Franch Directly Inhibits Proteolytic Activation of Kallikrein 5 and Cathelicidin Associated with Rosacea in Epidermal Keratinocytes. Molecules. 2020;25(23):1–17. 10.3390/molecules25235556

12. Park SM, Min B-G, Jung JY, et al. Combination of Pelargonium sidoides and Coptis chinensis root inhibits nuclear factor kappa B-mediated inflammatory response in vitro and in vivo. BMC Complement Alternat Med. 2018;18. 10.1186/s12906-018-2088-x

13. Wang L, Zhuang B, Wang S, et al. Study of coptidis rhizoma on the synergism to epilepsy and the regulation to brain delivery of antiepileptic drugs mediated by P-glycoprotein. Chin J Mod Appl Pharm. 2015;32:660–663.

14. Ma C, Xu T, Sun X, et al. Network pharmacology and bioinformatics approach reveals the therapeutic mechanism of action of baicalein in hepatocellular carcinoma. Evid Based Complement Alternat Med. 2019;2019. 10.1155/2019/7518374

15. Ru J, Li P, Wang J, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6. 10.1186/1758-2946-6-13

16. Xu X, Zhang W, Huang C, et al. A novel chemometric method for the prediction of human oral bioavailability. Int J Molec Sci. 2012;13:6964–6982. 10.3390/ijms13066964

17. Walters WP, Murcko MA. Prediction of “drug-likeness.” Adv Drug Deliv Rev. 2002;54:255–271. 10.1016/S0169-409X(02)00003-0

18. Feng W, Ao H, Yue S, et al. Systems pharmacology reveals the unique mechanism features of Shenzhu Capsule for treatment of ulcerative colitis in comparison with synthetic drugs. Sci Rep. 2018;8. 10.1038/s41598-018-34509-1

19. von Mering C, Jensen LJ, Snel B, et al. STRING: known and predicted protein-protein associations, integrated and transferred across organisms. Nucl Acids Res. 2005;33:D433–D437. 10.1093/nar/gki005

20. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44–57. 10.1038/nprot.2008.211

21. Chen L, Zhang Y-H, Wang S, et al. Prediction and analysis of essential genes using the enrichments of gene ontology and KEGG pathways. PLoS One. 2017;12. 10.1371/journal.pone.0184129

22. Carpten JD, Faber AL, Horn C, et al. A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature. 2007;448:439–U1. 10.1038/nature05933

23. Somers W, Stahl M, Seehra JS. 1.9 A crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling. EMBO J. 1997;16:989–997. 10.1093/emboj/16.5.989

24. Ek RO, Sirinyildiz F. Effects of melatonin at different doses on experimental epilepsy model induced by pentylenetetrazole. Meandros Med Dent J. 2021;22:177–186. 10.4274/meandros.galenos.2021.49358

25. Robinson SJ. Childhood epilepsy and autism spectrum disorders: psychiatric problems, phenotypic expression, and anticonvulsants. Neuropsychol Rev. 2012;22:271–279. 10.1007/s11065-012-9212-3

26. Mosinska P, Socala K, Nieoczym D, et al. Anticonvulsant activity of melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, in mice. Behav Brain Res. 2016;307:199–207. 10.1016/j.bbr.2016.03.036

27. Tombini M, Squitti R, Cacciapaglia F, et al. Inflammation and iron metabolism in adult patients with epilepsy: does a link exist? Epilepsy Res. 2013;107:244–252. 10.1016/j.eplepsyres.2013.09.010

28. Achar A, Ghosh C. Multiple hurdle mechanism and blood-brain barrier in epilepsy: glucocorticoid receptor-heat shock proteins on drug regulation. Neur Regener Res. 2021;16:2427–2428. 10.4103/1673-5374.313046

29. Howell KR, Hoda MN, Pillai A. VEGF activates NR2B phosphorylation through Dab1 pathway. Neurosci Lett. 2013;552:30–34. 10.1016/j.neulet.2013.07.032

30. Terasaki K, Gen Y, Iwai N, et al. SOX2 enhances cell survival and induces resistance to apoptosis under serum starvation conditions through the AKT/GSK-3 beta signaling pathway in esophageal squamous cell carcinoma. Oncol Lett. 2021;21(4):1–7. 10.3892/ol.2021.12530

31. Camaya I, Donnelly S, O’Brien B. Targeting the PI3K/Akt signaling pathway in pancreaticβ-cells to enhance their survival and function: An emerging therapeutic strategy for type 1 diabetes. 2022. J Diabetes. 10.1111/1753-0407.13252

32. Chen CY, Mei Q, Wang LL, et al. TIGAR suppresses seizures induced by kainic acid through inhibiting oxidative stress and neuronal apoptosis. Biochem Bioph Res Co. 2019.10.1016/j.bbrc.2019.05.156

33. Zhou J-H, Zhang T-T, Song D-D, et al. TIGAR contributes to ischemic tolerance induced by cerebral preconditioning through scavenging of reactive oxygen species and inhibition of apoptosis. Sci Rep. 2016;6. 10.1038/srep27096

34. Chen C, Mei Q, Wang L, et al. TIGAR suppresses seizures induced by kainic acid through inhibiting oxidative stress and neuronal apoptosis. Biochem Biophys Res Commun. 2019;515:436–441. 10.1016/j.bbrc.2019.05.156

35. Washington J, III, Kumar U, Medel-Matus J-S, et al. Cytokine-dependent bidirectional connection between impaired social behavior and susceptibility to seizures associated with maternal immune activation in mice. Epilepsy Behav. 2015;50:40–45. 10.1016/j.yebeh.2015.05.040

36. Chmielewska N, Maciejak P, Osuch B, et al. Pro-inflammatory cytokines, but not brain-and extracellular matrix-derived proteins, are increased in the plasma following electrically induced kindling of seizures. Pharmacol Rep. 2021;73(2):506–515. 10.1007/s43440-020-00208-w

37. Ocak O, Zorlu, Y, Kirkali G, et al. The role of plasma cytokine levels in the differential diagnosis of epileptic and psychogenic non-epileptic seizures. Ann Clin Anal Med. 2021; 12(S2):223–227.

38. Putra M, Gage M, Sharma S, et al. Diapocynin, an NADPH oxidase inhibitor, counteracts diisopropylfluorophosphate--induced long-term neurotoxicity in the rat model. Ann Ny Acad Sci. 2020;1479(1):75–93.

39. Ye F, Chen X-Q, Bao G-S, et al. Effect of topiramate on interleukin 6 expression in the hippocampus of amygdala-kindled epileptic rats. Exp Therap Med. 2014;7:223–227. 10.3892/etm.2013.1396

40. Cusick MF, Libbey JE, Doty DJ, et al. The role of peripheral interleukin-6 in the development of acute seizures following virus encephalitis. J Neurovirol. 2017;23(5):696–703. 10.1007/s13365-017-0554-8

41. Ozyilmaz E, Arpaci PU, Sayin S, et al. Inclusion complexes of water-soluble calix[n]arenes with quercetin: preparation, characterization, water solubility, and antioxidant features. Monatsh Chem. 2022;153(2):201–209. 10.1007/s00706-021-02885-6

42. Chen C, Zhong QX, Chen ZX. Improved aqueous solubility, bioaccessibility and cellular uptake of quercetin following pH-driven encapsulation in whey protein isolate. Int J Food Sci Tech. 2022. 10.1111/ijfs.15579

43. Dong Y-S, Wang J-L, Feng D-Y, et al. Protective effect of quercetin against oxidative stress and brain edema in an experimental rat model of subarachnoid hemorrhage. Int J Med Sci. 2014;11:282–290. 10.7150/ijms.7634

44. Wu Y, Wei HP, Li P, et al. Quercetin Administration Following Hypoxia-Induced Neonatal Brain Damage Attenuates Later-Life Seizure Susceptibility and Anxiety-Related Behavior: Modulating Inflammatory Response. Front Pediatr. 2022.10.3389/fped.2022.791815

45. Enogieru AB, Haylett W, Hiss DC, et al. Rutin as a Potent Antioxidant: Implications for Neurodegenerative Disorders. Oxid Med Cell Longev. 2018. 10.1155/2018/6241017

46. Lu Z, Sun W, Duan X, et al. Chemical constituents from Corydalis yanhusuo. Zhongguo Zhong Yao Za Zhi. 2012;37:235–237.

47. Wu J, Jin GZ. Tetrahydroberberine inhibits acetylcholine--induced K+ current in acutely dissociated rat hippocampal CA1 pyramidal neurons. Neurosci Lett. 1997;222:115–118. 10.1016/S0304-3940(97)13356-0

48. Wu J, Jin GZ. Tetrahydroberberine blocks membrane K+ chan-nels underlying its inhibition of intracellular message-me-diated outward currents in acutely dissociated CA1 neurons from rat hippocampus. Brain Res. 1997;775:214–218. 10.1016/S0006-8993(97)00960-8

49. Wu C, Yang K, Liu Q, et al. Tetrahydroberberine blocks ATP-sensitive potassium channels in dopamine neurons acutely-dissociated from rat substantia nigra pars com-pacta. Neuropharmacology. 2010;59:567–572. 10.1016/j.neuropharm.2010.08.018

50. Xu CQ. Research on the mechanism of neuronal apoptosis in Alzheimer’s disease and the effects of tetrohydroberberine on the apoptosis. Sheng Li Ke Xue Jin Zhan [Progr Physiol]. 1999;30:224–226.

51. Shuyu LI, Bo X, Fangfang BI, et al. The expression of XIAP mRNA and protein in the rat hippocampus and quercetin treatment following status epilepticus. Chin J Nerv Ment Dis. 2008;34:542–545.

52. Wu D, Zheng Z, Fan S, et al. Ameliorating effect of quercetin on epilepsy by inhibition of inflammation in glial cells. Exp Therap Med. 2020;20:854–859. 10.3892/etm.2020.8742